TUMOR PENETRATION
Live / Applied — Non-final action mailed (as of 29 Oct 2025)
What this means for you
Not registered yet, but its 09 Jun 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99225564
- Mark type
- Word mark
- Filed
- 09 Jun 2025
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: anti-cancer pharmaceutical preparations
- Class 042 — Scientific and technological services: pharmaceutical and therapeutics research and development services
Owner
- Bicara Therapeutics Inc., Boston, MA, US
Prosecution history
- 28 Apr 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Apr 2026 — ASSIGNED TO LIE
- 24 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Apr 2026 — TEAS AMENDMENT OF USE RECEIVED
- 24 Apr 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 21 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 21 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 29 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Oct 2025 — NON-FINAL ACTION E-MAILED
- 29 Oct 2025 — NON-FINAL ACTION WRITTEN
- 29 Oct 2025 — ASSIGNED TO EXAMINER
- 09 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 09 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Jun 2025 — NEW APPLICATION ENTERED